Wilterding Mark
SEC CIK 2107187 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RXST | RxSight, Inc. | CFO | 25.0K | — | $54.0K | 4 | 2026-02-28 | 2026-09-02 |
Most active insiders at RXST, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Wilterding Mark | CFO | — | $54.0K |
| 2 | Kurtz Ronald M MD | Chief Medical Off | — | $35.5K |
| 3 | Goldshleger Ilya | See remarks | — | $14.2K |
| 4 | Weinberg Eric | See remarks | — | $14.2K |
| 5 | Gaines Scott | Chief Customer Off | — | — |
| 6 | Fountain Tamara | Dir | — | — |
| 7 | Corley Jesse Anderson | Dir | — | — |
| 8 | Warner Robert Keith | Dir | — | — |
| 9 | Maniar Shweta | Dir | — | — |
| 10 | Andrews Julie | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-02 21:35 | 2026-08-31 | RXST | RxSight, Inc. | Wilterding Mark | CFO | M - OptEx | — | +20.4K | 32.8K | +165% | — |
| D | 2026-09-02 21:35 | 2026-09-02 | RXST | RxSight, Inc. | Wilterding Mark | CFO | S - Sale+OE | $6.96 | -7,765 | 25.0K | -24% | -$54.0K |
| D | 2026-03-03 | 2026-02-28 | RXST | RxSight, Inc. | Wilterding Mark | CFO | M - OptEx | — | +20.4K | 20.4K | New | — |
| D | 2026-03-03 | 2026-02-28 | RXST | RxSight, Inc. | Wilterding Mark | CFO | F - Tax | $7.61 | -8,068 | 12.4K | -39% | -$61.4K |
Purchase Sale Sale after option exercise All abbreviations